Operational Context

Mulesing is applied in extensive and semi-extensive wool production systems based on Merino-type sheep to reduce the long-term risk of breech and tail flystrike by Lucilia cuprina and related blowfly species.

The procedure alters skin morphology around the breech — reducing wrinkles and retention of faecal and urine soiling — in sheep phenotypes selected for high fleece weight and skin folds, which are associated with elevated flystrike susceptibility. It functions as a medium- to long-term risk-control measure that reduces the frequency and cost of individual flystrike treatment and monitoring in large flock, pasture-based systems with limited capacity for individual animal surveillance.

Mulesing is integrated into routine lamb-marking procedures alongside tail docking, castration, vaccination, and ear tagging, creating a single handling event for multiple husbandry interventions.

The practice is structurally embedded in fine and superfine Merino wool supply chains in Australia, where approximately 75–80% of sheep kept for wool have historically been reported as mulesed. In regions where mulesing is prohibited or commercially disfavoured, flystrike control relies on alternative combinations of genetic selection for plain-bodied phenotypes, crutching, dagging, chemical prophylaxis, and strategic shearing.

Biological Impact

Mulesing produces acute physiological stress, sustained open wounds, and documented medium-term behavioural and growth effects.

Plasma cortisol concentrations are elevated for approximately 24–48 hours post-procedure relative to baseline and non-mulesed controls. Behavioural indicators of acute pain in the post-procedure period include statue standing — immobility with rigid posture — hunched stance, reduced lying, delayed suckling, reduced grazing, abnormal gait, and handler avoidance. Acute behavioural signs peak within the first 24 hours and decrease over 24–48 hours, though wound-associated altered behaviours including reduced activity can persist beyond this period.

Weight gain is reduced for up to 14 days following mulesing relative to non-mulesed lambs, indicating a short-term growth impact associated with the procedure.

Wound healing under commercial conditions requires approximately 5–7 weeks for re-epithelialisation and stable scar formation, with open wounds present for a substantial portion of this period.

Documented and identified complications include wound infection, myiasis of the mulesing wound, fly attraction to exudative tissue, and delayed healing. Quantitative complication rates are not consistently reported across studies.

A quantitative risk model comparing lifetime welfare challenge scores across breech-strike management options found that in the first year of life, mulesed lambs had higher welfare challenge scores than non-mulesed lambs; across five years, non-mulesed sheep had higher cumulative scores than those managed via plastic clips, with mulesed animals intermediate. The model depends on expert-elicited severity weightings and its numeric outputs carry methodological uncertainty.

Studies comparing mulesing with and without analgesia document lower cortisol responses and fewer pain-related behaviours when local anaesthetics and systemic NSAIDs are used, relative to unmedicated procedures; these effects are time-limited and dependent on the pharmacological profile of the products applied.

Scale & Distribution

Global prevalence: High within Merino wool systems; low at whole-sheep-population scale
Primary regions: Australia is the primary and near-exclusive jurisdiction where mulesing is practiced at commercial scale; New Zealand previously used the practice but has prohibited it
Species coverage: Specific — Merino and Merino-derived sheep
Trend: Declining — prohibited in New Zealand; contested but likely slowly declining or regionally variable in Australia; not reported as a standard practice in other major wool-producing countries

Australia is the only country where mulesing is documented as current commercial practice at scale. Estimates that 75–80% of Australian wool sheep continue to be mulesed derive from advocacy reports and National Wool Declaration data; independent nationally representative prevalence data are limited. Within Australia, prevalence varies by region, enterprise type, and adoption of genetic and alternative management approaches. Other significant wool producers — Argentina, South Africa, Norway, the United Kingdom, and the United States — report production from non-mulesed sheep as standard.

Regulatory Framing

Mulesing is permitted in Australia under state and territory animal welfare legislation as a classified acceptable husbandry practice, and prohibited in New Zealand.

In Australia, mulesing is classified as an acceptable husbandry procedure under the Australian Animal Welfare Standards and Guidelines for Sheep and preceding state codes of practice. This classification provides de facto exemption from general animal cruelty provisions when the procedure is performed as specified. Analgesia requirements and age limits vary between states and territories; some jurisdictions mandate or encourage pain relief for mulesing above specified ages, but comprehensive uniform national requirements are not fully harmonised. Federal-level frameworks do not explicitly ban mulesing. Industry commitments to phase out the practice — including an abandoned 2010 target by Australian Wool Innovation — have not produced statutory prohibition. Market mechanisms including retailer sourcing policies and wool certification schemes influence practice through price signals for non-mulesed wool.

In New Zealand, mulesing is prohibited under animal welfare regulations and is no longer a legally permitted practice for flystrike prevention.

In the European Union and other major wool-importing regions, no directive specifically addresses mulesing; mulesing is not practiced domestically and is not explicitly covered by existing animal welfare legislation. Retailer and brand standards in importing markets increasingly specify non-mulesed sourcing, creating supply-chain segmentation based on mulesing status.

Regulatory variation produces commercial differentiation: mulesed wool production is concentrated in Australia, while non-mulesed production in other countries is marketed as a distinct supply-chain attribute.

Terminology

Mulesing, surgical mulesing, breech mulesing, traditional mulesing, modified mulesing, live lamb cutting, breech modification, breech strike surgery, mulesed wool, non-mulesed wool, NM wool, flystrike surgery, breech surgery, plastic skin-fold clips, clips mulesing, breech clips

Editorial correction notice

Scale distribution — prevalence data: Estimates that 75–80% of Australian wool sheep are mulesed derive from advocacy and NGO reports using National Wool Declaration categories and producer surveys as indirect indicators. Independent, nationally representative prevalence data are limited. Historic figures of approximately 80% derive from older studies and may not reflect current regional variation or recent transitions.

Biological impact — complication rates: Wound infection rates, myiasis of mulesing wounds, and other complication frequencies are not consistently quantified in peer-reviewed literature. Available data focus on acute cortisol responses, behavioural indicators, and short-term growth impacts; systematic epidemiological complication datasets are not available.

Biological impact — lifetime welfare model: The quantitative risk model comparing mulesing with alternative management options depends on expert-elicited welfare severity weightings. Its numeric outputs embed normative judgements and should not be treated as objective welfare metrics.

Regulatory framing — Australian state variation: Precise analgesia requirements and age limits for mulesing vary across Australian states and territories and are subject to ongoing regulatory revision. State-specific legal mapping requires verification against current primary legislation rather than secondary summaries.

Inventory note: Mulesing is not listed in the current SE practice inventory. This record adds it under Mutilation & Body Alteration. The se-architecture-practices-cpt.txt inventory requires updating to include this record.